SIRT3 and lip and oral cavity carcinoma: A study conducted by Ling Tao also showed that the green tea catechin (–)-epigallocatechin-3-gallate (EGCG) appears to be a promising medicine because it inhibits SIRT3 activity in oral cancer cells but activates SIRT3 in normal cells (Tao, Park & Lambert, 2015).